[PDF] Top 20 Hormone Therapy and Venous Thromboembolism: Early Results from the E3N Prospective Study

... Hormone Therapy and Venous Thromboembolism: Early Results from the E3N Prospective Study Marianne Canonico, Agnès Fournier, Laure Carcaillon, Valérie Olié, Geneviève Plu-Bureau, Emmanuel[r] ... Voir le document complet

... in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal ... Voir le document complet

... between early and late initiators, including the positive association between HT and verbal ...this study age at HT initiation was examined, rather than timing in relation to the ... Voir le document complet

... - Hormone replacement therapy - Menopause - Progestagens - Progesterone Introduction Estrogen–progestagen postmenopausal hormone replacement therapy (HRT) has been classified as carcinogenic ... Voir le document complet

... Our results suggest that the +331G/A hPR polymorphism may be not functional in endothelial and smooth muscle cells of the vessel ...hPR and VTE and that the progestogens ... Voir le document complet

... our study is that observational studies are subject to bias. The validity of the ESTHER study has already been discussed (3, 4, ...In the present analysis, poten- tial biases include ... Voir le document complet

... used the final data of the EStrogen and THromboEmbolism Risk (ESTHER) study performed in France between 1998 and ...2006. Study design has been described [9, ...to ... Voir le document complet

... met the ATS criteria, and there was a consistent reported date of asthma onset (time of first attack between 1990 and ...asthma). Results were similar to those observed when all cases of ... Voir le document complet

... of the study Previous reviews and meta-analysis regarding hormone therapy and risk of venous thromboembolism focused on oral oestrogen use and failed to take ... Voir le document complet

... 3,9,11,28-30 and a meta-analysis 31 have shown an increase in risk with increased duration of HRT ...In the present study, there was a significant increase in risk with very short exposure to ... Voir le document complet

... reach the signification (Hazard ...to the other progestogens, the ESTHER (EStrogen and THromboEmbolism Risk) Study, a French case/control study of VTE among postmenopausal ... Voir le document complet

... 13, and 14), age at first full-term pregnancy (cut points: 23, 26, and 30 years), parity (0, 1-3, and z4), history of benign breast disease (yes/no), marital status (if ever married or not), ... Voir le document complet

... our study lies on the regular updates of exposure, which limited classification bias and allowed to account for possible changes over time in the types of hormones used by a woman, by ... Voir le document complet

... personality and physical ...examining the role of other ...constructs from various conceptual models may overlap in their ...hostility and CHD-prone personality type are both assumed to be ... Voir le document complet

... weekdays and 1 weekend day) ...of the study website to declare all foods and beverages consumed during a 24h-period: three main meals (breakfast, lunch, dinner) or any other eating ...alcohol ... Voir le document complet

... friends or neighbors 3. Cared for a sick or disabled adult. For each activity respondents were asked whether they engaged in one or more of these activities during the last month and, if so, how often. ... Voir le document complet

... our study the role of age at menarche was apparent only before adjustment for age at onset of regular cycling, with RR of ...(0.77–1.04), and 0.86 (0.71– 1.04), corresponding to menarche at 12, 13, ... Voir le document complet

... of the GRSs that we examined was reported by de Haan et ...rs2066865, and F11 gene ...in the TiC ...show the highest individual ORs for VTE risk. This fact clearly indicates the limited ... Voir le document complet

... menopause and had a higher cholesterol level than women who had never used ...kg/m²/year) and this difference was significant even after adjustment for age and BMI at the start of follow-up (P ... Voir le document complet

... positive). The distribution of the covariates used as confounders is presented in Table I by history of infertility treatment for parous and nulliparous ...corpulent and more often post- ... Voir le document complet